National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
Department of Business Group Insurance & Reinsurance, PICC Property and Casualty Company Limited Guangdong Branch, Guangzhou, Guangdong, 510600, China.
J Clin Endocrinol Metab. 2023 Jun 16;108(7):1824-1834. doi: 10.1210/clinem/dgad036.
It remains controversial whether the choice of the daily eating window early or later in time-restricted eating (TRE) intervention (early or later TRE) has different effects on weight loss and metabolic health.
A network meta-analysis was performed to evaluate the efficacy between early and later TRE in adults with obesity or overweight.
We searched PubMed, Embase, Web of Science, and Cochrane Library for randomized controlled trials (RCTs) published until October 16, 2022. We conducted a network meta-analysis to evaluate the efficacy of early and later TRE on body weight and metabolic parameters, including glycemic metabolism, blood pressure, and lipid profiles.
Twelve RCTs with 730 obese or overweight adults were included in this meta-analysis. Early TRE and later TRE both elicited moderate reductions in body weight and insulin resistance (IR) (homeostasis model assessment of IR) when compared to non-TRE. Interestingly, early TRE showed more effectiveness than later TRE in improving IR (early vs later TRE: -0.44; 95% CI, -0.86 to -0.02; P < .05), whereas no statistically significant difference was detected in weight loss (early vs later TRE: -0.31 kg; 95% CI, -1.15 to 0.53 kg; P >.05). In addition, early TRE rather than later TRE showed significant benefits in glycemic metabolism and blood pressure when compared to non-TRE. No significant differences between early and later TRE were observed for fasting blood glucose, blood pressure, and lipid profiles.
This meta-analysis suggests that people may choose early TRE for more effective weight management and metabolic benefits. Nevertheless, further large-scale RCTs are warranted to verify our findings.
限时进食(TRE)干预中进食窗口早晚的选择对减肥和代谢健康的影响是否不同,这仍然存在争议。
进行网状荟萃分析,以评估肥胖或超重成年人中早期和晚期 TRE 的疗效。
我们检索了 PubMed、Embase、Web of Science 和 Cochrane Library 截至 2022 年 10 月 16 日发表的随机对照试验(RCT)。我们进行了网状荟萃分析,以评估早期和晚期 TRE 对体重和代谢参数(包括血糖代谢、血压和血脂谱)的疗效。
该荟萃分析纳入了 12 项 RCT,共 730 名肥胖或超重成年人。与非 TRE 相比,早期 TRE 和晚期 TRE 均能适度降低体重和胰岛素抵抗(IR)(稳态模型评估的 IR)。有趣的是,与晚期 TRE 相比,早期 TRE 在改善 IR 方面更有效(早期 vs 晚期 TRE:-0.44;95%CI,-0.86 至 -0.02;P <.05),而在体重减轻方面无统计学差异(早期 vs 晚期 TRE:-0.31kg;95%CI,-1.15 至 0.53kg;P >.05)。此外,与非 TRE 相比,早期 TRE 而不是晚期 TRE 在血糖代谢和血压方面显示出显著益处。早期 TRE 和晚期 TRE 之间在空腹血糖、血压和血脂谱方面没有显著差异。
这项荟萃分析表明,人们可能会选择早期 TRE 以获得更有效的体重管理和代谢益处。然而,需要进一步的大规模 RCT 来验证我们的发现。